CRISPR & Cas Genes Market (By Product and Services; By Application: Agricultural and Biomedical; End-User: Contract Research Organizations (CROs), Academics & Government Research Institutes and Biotechnology & Pharmaceutical Companies) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024 - 2033

CRISPR & Cas Genes Market Size and Growth 2024 to 2033

The global CRISPR & Cas genes market size was valued at USD 3.08 billion in 2023 and is anticipated to reach around USD 14.94 billion by 2033, growing at a CAGR of 16.9% from 2024 to 2033.

CRISPR and Cas Genes Market Size 2024 to 2033

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Key Takeaways

  • North America led the global market with the highest market share of 38.64% in 2023.
  • Asia Pacific is projected to expand at the fastest CAGR during the forecast period.
  • By Application, the biomedical segment registered the maximum market share of 90% in 2023.
  • By Product & Service, the product segment recorded more than 75% of revenue share in 2023.
  • By End-user, the biotechnology and pharmaceutical segment had the largest market share in 2023.

U.S. CRISPR & Cas Genes Market Size and Growth 2024 to 2033

The U.S. CRISPR & Cas genes market size was estimated at USD 830 million in 2023 and is predicted to be worth around USD 4,270 million by 2033, at a CAGR of 17.5% from 2024 to 2033.

U.S. CRISPR & Cas Genes Market Size 2024 to 2033

CRISPR and Cas genes market in North America accounted for noteworthy revenue stake compared with markets in other regions, in 2023. Extraordinary implementation of advance technologies together with existence of foremost companies in market is estimated to boost development of North America CRISPR and cas genes industry. Besides, advantageous government initiatives and an upsurge in the numeral of research collaboration are certain factors anticipated to up turn the market growth. U.S. has the prevalent revenue contribution on account of reassuring healthcare policies, established healthcare sector and the high prevalence of chronic illnesses.

Asia Pacific is expected to observer the firmest development over the prediction period. China grasps a noteworthy place in the global CRISPR market arena and is progressively discovering genome-editing for the improvement of medicines. It has introduced numerous CRISPER-based clinical trials, particularly for treatment of cancer.At present, China hosts the prevalent number of clinical trials including CRISPR technology across the globe.Further, it holds more than 858 publicly accessible CRISPR patent applications, particularly in agricultural and other sectors. Furthermore, more than 20 research groups practice these molecular tools for crop variation to advance agricultural productivity in China.  In turn, these influences are projected to lift the progression of the market in Asia Pacific.

U.S. CRISPR & Cas Genes Market Size 2024 to 2033

Growth Factors

Escalating private and government spending for enhancement of innovative therapies is tremendously fuelling the growth of CRISPR and Cas genes market. Cumulative focus on development of innovative therapeutics on account of emergent pervasiveness of different genetic ailments and cancer is key influence projected to stimulate the progress of CRISPR and Cas genes marketplace during years to come. Further high-tech progressions in CRISPR sector are also estimated to propel demand in the target market during forthcoming years.

Additionally, intensifying studies and research regarding CAS and CRISPR gene technology by different researchers across the world are further pushing revenue growth in this market arena. Besides, at present, numerous organizations are also concentrating on introducing novel clinical trials for the Cas and CRISPR gene for cancer treatment. For occurrence, CRISPR Therapeutics and Vertex introduced the pioneering in-human clinical trial of CRISPR genome editing technology which was subsidized by the U.S. companies in 2021.

Report Scope of the CRISPR & Cas Genes Market

Report Coverage Details
Market Size in 2023 USD 3.08 Billion 
Market Size by 2033 USD 14.94 Billion 
Growth Rate from 2024 to 2033 CAGR of 16.9%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Product & Services, By Application, and By End User
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Application Insights

Among different application segment assessed in this research study, biomedical application occupied more than 90% share of the total market in 2023. This tremendous revenue chunk is attributable to amplified practice of CRISPR in biomedical research. There is a substantial escalation in the number of research studies engaging this method for editing genomes of induced pluripotent stem cells and human somatic cells. Furthermore, introduction of better-quality delivery systems and employment of nano-carriers have suggestively enriched the effectiveness and specificity of CRISPR and Cas technology across the biomedical sector.

Product & Service Insights

In terms of revenue, product segment ruled the global market with stake of more than 75% of the total market in 2023. Some of the crucial factors supporting this growth include constant growth of engineered enzymes and amalgamation of diverse enzymes, like Cas12a and Cas9. This is due to engineered enzymes deliver more flexibility in experiments, and henceforth is progressively being implemented by researchers.

End-user Insights

The biotechnology and pharmaceutical companies division occupied for the biggest share of the total market revenue. Impending clinical applications of CRISPR-Cas9 have fortified pharmaceutical start-ups to advance products using CRISPR-mediated gene-editing methods. Furthermore, the industry has perceived mergers among protruding and evolving companies with CRISPR-based services and product portfolios.

CRISPR & Cas Genes Market Companies

  • Caribou Biosciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Cellectis
  • AstraZeneca
  • Editas Medicine, Inc.
  • Addgene
  • Egenesis
  • Horizon Discovery Group Plc
  • Intellia Therapeutics, Inc.
  • Genscrip
  • Danaher Corporation
  • Lonza
  • Merck KGaA
  • Synthego
  • Mammoth Biosciences
  • Inscripta, Inc.
  • Cibus
  • New England BioLabs
  • Takara Bio, Inc.

Segments Covered in the Report

By Product & Service

  • By Service
    • Microbial Gene Editing
    • Cell Line Engineering
    • gRNA Design
    • DNA Synthesis
  • By Product
    • Design Tool
    • Kits & Enzymes
    • Libraries
    • Antibodies
    • Others

By Application

  • Agricultural
  • Biomedical
    • Functional Genomics
    • Genome Engineering
    • Disease Model Studies
    • Epigenetics
    • Others

End-use Outlook

    • Contract Research Organizations (CROs),
    • Academics & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

Frequently Asked Questions

What is the current size of the global CRISPR & Cas genes market?
The global CRISPR & Cas genes market value is projected to reach around USD 14.94 billion by 2033.
What is the CRISPR & Cas genes market growth?
The global CRISPR & Cas genes market is expected to grow at a CAGR of 16.9% from forecast period 2024 to 2033.
Which factor contributing the CRISPR & Cas genes market growth?
Progressions in the arena of genome editing have eased augmented adoption of CRISPR-Cas systems in diagnostics and in the valuation of evolutionary study in prokaryotes. This method is precisely utilized to comprehend the evolution of bacteria. Government organizations across the world have stimulated spending for genome editing developments thereby offering alluring growth prospects for global CRISPR and Cas genes market growth.
Which region accounted largest market share in the CRISPR & Cas genes market?
In 2023, North America conquered the whole CRISPR and Cas genes sector on account of reasons including occurrence of key companies, snowballing finance in genomics and biotechnology programs, and proven healthcare infrastructure among others.
Who are the top key players of CRISPR & Cas genes market?
Particular players contending in this industry are Caribou Biosciences, Inc., Editas Thermo Fisher Scientific, Takara Bio Inc, OriGene Technologies, Inc., Merck KGaA, Horizon Discovery Ltd., Addgene, Medicine, Crispr Therapeutics, and Mirus Bio LLC amongst others.
Which segment accounted for the largest CRISPR & Cas genes market share?
The biotechnology and pharmaceutical companies division occupied for the biggest share of the total market revenue.


   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500


No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample